
浏览全部资源
扫码关注微信
1.233004 安徽 蚌埠,蚌埠医科大学第一附属医院神经内科
2.400042 重庆,陆军特色医学中心神经内科
[周华东,E-mail:zhouhuad@163.com ZHOU Huadong, E-mail: zhouhuad@163.com
收稿:2024-04-18,
修回:2024-05-14,
纸质出版:2024-11-15
移动端阅览
廖旗荣, 杨红岩, 卢静, 等. 胰淀素对阿尔茨海默病小鼠学习和记忆能力以及Akt信号通路的影响[J]. 陆军军医大学学报, 2024,46(21):2467-2474.
Qirong LIAO, Hongyan YANG, Jing LU, et al. Effect of amylin on learning and memory abilities and Akt signaling pathway in mice with Alzheimer's disease[J]. Journal of Army Medical University, 2024, 46(21): 2467-2474.
廖旗荣, 杨红岩, 卢静, 等. 胰淀素对阿尔茨海默病小鼠学习和记忆能力以及Akt信号通路的影响[J]. 陆军军医大学学报, 2024,46(21):2467-2474. DOI: 10.16016/j.2097-0927.202404087.
Qirong LIAO, Hongyan YANG, Jing LU, et al. Effect of amylin on learning and memory abilities and Akt signaling pathway in mice with Alzheimer's disease[J]. Journal of Army Medical University, 2024, 46(21): 2467-2474. DOI: 10.16016/j.2097-0927.202404087.
目的
2
探讨胰淀素[也称为胰岛淀粉样多肽(islet amyloid polypeptide,IAPP)]对APP/PS1小鼠的学习和记忆能力,以及磷脂酰肌醇3-激酶/蛋白激酶B(PI3K/Akt)信号通路的影响。
方法
2
依据随机数字表法将APP/PS1小鼠分为阿尔茨海默病(Alzheimer’s disease,AD)组、IAPP组,每组10只。IAPP组小鼠腹腔内注射0.5 μmol/L的IAPP,每日1次,AD组小鼠腹腔注射相同剂量的PBS。2组小鼠干预时间均为10周。采用Morris水迷宫检测小鼠学习记忆能力,HE染色观察小鼠脑海马组织病理形态变化,透射电镜观察小鼠海马神经元超微结构;生化方法检测小鼠海马组织谷胱甘肽过氧化物酶(GSH-Px)、丙二醛(MDA)水平、超氧化物歧化酶(SOD)
酶联免疫吸附实验(ELISA)试剂盒检测炎症因子白细胞介素6(IL-6)、肿瘤坏死因子α(TNF-α)和白细胞介素1β(IL-1β)水平以及Aβ42的含量;Western blot检测PI3K/Akt蛋白表达水平。
结果
2
与AD组相比,IAPP组小鼠平台潜伏期减少(
P
<0.01),穿越平台次数和探索隐藏平台时间均增加(
P
<0.01),小鼠游泳速度无明显差异。HE染色结果显示与AD组相比,IAPP组小鼠海马组织神经细胞数目较多,排列整齐(
P
<0.05)。免疫组化结果显示与AD组相比,IAPP组小鼠海马组织Aβ蛋白降低(
P
<0.01)。与AD组相比,IAPP组小鼠海马组织氧化应激水平和炎症因子水平降低(
P
<0.01)。与AD组相比,IAPP组小鼠超微结构观察到神经元线粒体结构较为清晰、空泡化减少,微管、微丝排列较为整齐。与AD组相比,IAPP组小鼠p-PI3K/PI3K、p-Akt/Akt蛋白相对表达量均升高(
P
<0.01)。
结论
2
胰淀素能够减少海马组织氧化应激和炎症反应,改善AD小鼠学习记忆能力,并且促进PI3K/Akt信号通路的激活。
Objective
2
To investigate the effects of amylin
also known as islet amyloid polypeptide (IAPP)
on learning and memory abilities and the phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) signaling pathway in APP/PS1 mice.
Methods
2
A total of 20 APP/PS1 mice were randomly divided into Alzheimer's disease (AD) group and IAPP group
with 10 mice in each group. The mice in the latter group were given an intraperitoneal injection of 0.5 μmol/L IAPP
and those of the former group received same dose of PBS. Both interventions were given once per day
for 10 weeks. Morris water maze test was used to measure the learning and memory abilities; HE staining was employed to observe the pathological changes in the hippocampus; Transmission electron microscopy was utilized to observe the ultrastructure of hippocampal neurons; Biochemical assay were conducted to detect the contents of glutathione peroxidase (GSH-Px)
malondialdehyde (MDA) and superoxide dismutase (SOD) in hippocampal tissues; ELISA was applied to measure the levels of inflammatory factors such as IL-1β
IL-6
and TNF-α as well as content of Aβ42 in hippocampal tissues; And Western blotting was conducted to detect the expression of PI3K/Akt proteins.
Results
2
Compared with the AD group
significantly shorter platform latency (
P
<
0.01)
increased number of traversing the platform and longer time to explore the hidden platform (
P
<
0.01) were observed in the IAPP group
but no such difference was seen in the swimming speed of the mice. HE staining displayed that the IAPP group had more and well-arranged nerve cells in the hippocampal tissue when compared with the AD group (
P
<
0.05). Lower Aβ protein expression (
P
<
0.01)
reduced oxidative stress and decreased contents of inflammatory factors (
P
<
0.01) in hippocampal tissue were observed in the IAPP group than the AD group. The IAPP group showed clearer structure of neuronal mitochondria
reduced vacuolization
and better arranged microtubules and microfilaments
and elevated expression of p-PI3K/PI3K and p-Akt/Akt proteins when compared with the AD group (
P
<
0.01).
Conclusion
2
Amylin can reduce oxidative stress and inflammatory responses
improve learning and memory abilities in AD mice
and promote the activity of PI3K/Akt signaling pathway.
PENG D Z, XU S M, ZOU T, et al . Safety, tolerability, pharmacokinetics and effects of diet on AD16, a novel neuroinflammatory inhibitor for Alzheimer's disease: a randomized phase 1 study[J ] . BMC Med, 2023, 21(1): 459. DOI: 10.1186/s12916-023-03126-9.
SCHELTENS P, DE STROOPER B, KIVIPELTO M, et al . Alzheimer's disease[J ] . Lancet, 2021, 397(10284): 1577-1590. DOI: 10.1016/S0140-6736(20)32205-4.
XIONG J, KANG S S, WANG Z H, et al . FSH blockade improves cognition in mice with Alzheimer's disease[J ] . Nature, 2022, 603(7901): 470-476. DOI: 10.1038/s41586-022-04463-0.
TORAL-RIOS D, LONG J M, ULRICH J D, et al . Cholesterol 25-hydroxylase mediates neuroinflammation and neurodegeneration in a mouse model of tauopathy[J ] . J Exp Med, 2024, 221(4): e20232000. DOI: 10.1084/jem.20232000.
CORRIGAN R R, PIONTKIVSKA H, CASADESUS G. Amylin pharmacology in Alzheimer's disease pathogenesis and treatment[J]. Curr Neuropharmacol, 2022, 20(10): 1894-1907. DOI: 10.2174/1570159X19666211201093147.
YANG C Z, WANG S H, ZHANG R H, et al . Neuroprotective effect of astragalin via activating PI3K/Akt-mTOR-mediated autophagy on APP/PS1 mice[J ] . Cell Death Discov, 2023, 9(1): 15. DOI: 10.1038/s41420-023-01324-1..
HUANG J, HUANG N Q, QIU Y, et al . Dendrobium nobile Lindl. alkaloid decreases Tau hyperphosphorylation via regulatingPI3K/Akt/GSK-3β pathway in vitro and in vivo [J ] . J Ethnopharmacol, 2024, 322: 117592. DOI: 10.1016/j.jep.2023.117592..
GOUVEIA F, FONSECA C, SILVA A, et al . Intranasal irbesartan reverts cognitive decline and activates the PI3K/AKT pathway in an LPS-induced neuroinflammation mice model[J ] . Int Immunopharmacol, 2024, 128: 111471. DOI: 10.1016/j.intimp.2023.111471.
ZHU H, WANG X, WALLACK M, et al . Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer's disease[J ] . Mol Psychiatry, 2015, 20(2): 252-262. DOI: 10.1038/mp.2014.17.
MOHAMED L A, ZHU H H, MOUSA Y M, et al . Amylin enhances amyloid-β peptide brain to blood efflux across the blood-brain barrier[J ] . J Alzheime rs Dis, 2017, 56(3): 1087-1099. DOI: 10.3233/JAD-160800.
DHARMARAJ G L, ARIGO F D, YOUNG K A, et al . Novel amylin analogues reduce amyloid-β cross-seeding aggregation and neurotoxicity[J ] . J Alzheimers Dis, 2022, 87(1): 373-390. DOI: 10.3233/JAD-215339.
CHEN H C, CAO J X, CAI Y T, et al . Interaction of human IAPP and Aβ 1-42 aggravated the AD-related pathology and impaired the cognition in mice[J ] . Exp Neurol, 2020, 334: 113490. DOI: 10.1016/j.expneurol.2020.113490..
YANG Y Y, REN Y T, JIA M Y, et al . The human islet amyloid polypeptide reduces hippocampal tauopathy and behavioral impairments in P301S mice without inducing neurotoxicity or seeding amyloid aggregation[J ] . Exp Neurol, 2023, 362: 114346. DOI: 10.1016/j.expneurol.2023.114346.
MARTINEZ-VALBUENA I, VALENTI-AZCARATE R, AMAT-VILLEGAS I, et al . Amylin as a potential link between type 2 diabetes and alzheimer disease[J ] . Ann Neurol, 2019, 86(4): 539-551. DOI: 10.1002/ana.25570.
ZHU H H, TAO Q S, ANG T F A, et al . Association of plasma amylin concentration with alzheimer disease and brain structure in older adults[J ] . JAMA Netw Open, 2019, 2(8): e199826. DOI: 10.1001/jamanetworkopen.2019.9826.
MIETLICKI-BAASE E G. Amylin in Alzheimer's disease: pathological peptide or potential treatment?[J]. Neuropharmacology, 2018, 136(Pt B): 287-297. DOI: 10.1016/j.neuropharm.2017.12.016.
BAKOU M, HILLE K, KRACKLAUER M, et al . Key aromatic/hydrophobic amino acids controlling a cross-amyloid peptide interaction versus amyloid self-assembly[J ] . J Biol Chem, 2017, 292(35): 14587-14602. DOI: 10.1074/jbc.M117.774893..
GE X W, YANG Y, SUN Y X, et al . Islet amyloid polypeptide promotes amyloid-beta aggregation by binding-induced Helix -unfolding of the amyloidogenic core[J ] . ACS Chem Neurosci, 2018, 9(5): 967-975. DOI: 10.1021/acschemneuro.7b00396..
NA H N, TIAN H, ZHANG Z R, et al . Oral amylin treatment reduces the pathological cascade of Alzheimer's disease in a mouse model[J ] . Am J Alzheimers Dis Other Demen, 2021, 36: 15333175211012867. DOI: 10.1177/15333175211012867.
NASSAR S Z, BADAE N M, ISSA Y A. Effect of amylin on memory and central insulin resistance in a rat model of Alzheimer's disease[J]. Arch Physiol Biochem, 2020, 126(4): 326-334. DOI: 10.1080/13813455.2018.1534244.
GRIZZANTI J, CORRIGAN R, CASADESUS G. Neuroprotective effects of amylin analogues on Alzheimer's disease pathogenesis and cognition[J]. J Alzheimers Dis, 2018, 66(1): 11-23. DOI: 10.3233/JAD-180433.
PATRICK S, CORRIGAN R, GRIZZANTI J, et al . Neuroprotective effects of the amylin analog, pramlintide, on Alzheimer's disease are associated with oxidative stress regulation mechanisms[J ] . J Alzheimers Dis, 2019, 69(1): 157-168. DOI: 10.3233/JAD-180421.
GAN Q N, YAO H B, NA H N, et al . Effects of amylin against amyloid-β-induced tauopathy and synapse loss in primary neurons[J ] . J Alzheimers Dis, 2019, 70(4):1025-1040. DOI: 10.3233/JAD-190161.
HE S, SHI J H, MA L N, et al . Total ginsenosides decrease Aβ production through activating PPARγ[J ] . Biomed Pharmacother, 2024, 174: 116577. DOI: 10.1016/j.biopha.2024.116577.
TU S C, OKAMOTO S I, LIPTON S A, et al . Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease[J ] . Mol Neurodegener, 2014, 9: 48. DOI: 10.1186/1750-1326-9-48.
BUTTERFIELD D A. Perspectives on oxidative stress in Alzheimer's disease and predictions of future research emphases[J]. J Alzheimers Dis, 2018, 64(s1): S469-S479. DOI: 10.3233/JAD-179912.
HE Z J, LI X Q, WANG Z, et al . Esculentoside A alleviates cognitive deficits and amyloid pathology through peroxisome proliferator-activated receptor γ-dependent mechanism in an Alzheimer's disease model[J ] . Phytomedicine, 2022, 98: 153956. DOI: 10.1016/j.phymed.2022.153956.
LI Q Y, WANG J H, LI Y W, et al . Neuroprotective effects of salidroside administration in a mouse model of Alzheimer's disease[J ] . Mol Med Rep, 2018, 17(5): 7287-7292. DOI: 10.3892/mmr.2018.8757.
YANG P, SHENG D Y, GUO Q, et al . Neuronal mitochondria-targeted micelles relieving oxidative stress for delayed progression of Alzheimer's disease[J ] . Biomaterials, 2020, 238: 119844. DOI: 10.1016/j.biomaterials.2020.119844.
LI S, TIAN Z Q, XIAN X H, et al . Catalpol rescues cognitive deficits by attenuating amyloid β plaques and neuroinflammation[J ] . Biomedecine Pharmacother, 2023, 165: 115026. DOI: 10.1016/j.biopha.2023.115026.
GUADAGNO J, XU X, KARAJGIKAR M, et al . Microglia-derived TNFα induces apoptosis in neural precursor cells via transcriptional activation of the Bcl-2 family member Puma [J ] . Cell Death Dis , 2013, 4(3): e538. DOI: 10.1038/cddis.2013.59..
TIAN Z Q, ZENG W F, YAN C H, et al . SRPK2 expression and beta-amyloid accumulation are associated with BV2 microglia activation[J ] . Front Integr Neurosci, 2021, 15: 742377. DOI: 10.3389/fnint.2021.742377.
CALVO-RODRIGUEZ M, KHARITONOVA E K, SNYDER A C, et al . Real-time imaging of mitochondrial redox reveals increased mitochondrial oxidative stress associated with amyloid β aggregates in vivo in a mouse model of Alzheimer's disease[J ] . Mol Neurodegener, 2024, 19(1): 6. DOI: 10.1186/s13024-024-00702-2..
VON BERNHARDI R, EUGENÍN J. Alzheimer's disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms[J]. Antioxid Redox Signal, 2012, 16(9): 974-1031. DOI: 10.1089/ars.2011.4082.
CAO H, ZUO C C, GU Z Y, et al . High frequency repetitive transcranial magnetic stimulation alleviates cognitive deficits in 3xTg-AD mice by modulating the PI3K/Akt/GLT-1 axis[J ] . Redox Biol, 2022, 54: 102354. DOI: 10.1016/j.redox.2022.102354.
YOON J H, LEE N, YOUN K, et al . Dieckol ameliorates aβ production via PI3K/akt/GSK-3β regulated APP processing in SweAPP N2a cell[J ] . Mar Drugs, 2021, 19(3): 152. DO I: 10.3390/md19030152..
LU C Y, DAY C H, KUO C H, et al . Calycosin alleviates H 2 O 2 -induced astrocyte injury by restricting oxidative stress through the Akt/Nrf2/HO-1 signaling pathway[J ] . Environ Toxicol, 2022, 37(4): 858-867. DOI: 10.1002/tox.23449..
0
浏览量
213
下载量
3
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621